Attached files

file filename
EX-10.40 - EX-10.40 - Amphastar Pharmaceuticals, Inc.amph-20201231ex10400a25b.htm
EX-32.2 - EX-32.2 - Amphastar Pharmaceuticals, Inc.amph-20201231ex322472937.htm
EX-32.1 - EX-32.1 - Amphastar Pharmaceuticals, Inc.amph-20201231ex321fced5d.htm
EX-31.2 - EX-31.2 - Amphastar Pharmaceuticals, Inc.amph-20201231ex3124acfaf.htm
EX-31.1 - EX-31.1 - Amphastar Pharmaceuticals, Inc.amph-20201231ex311273657.htm
EX-23.1 - EX-23.1 - Amphastar Pharmaceuticals, Inc.amph-20201231ex231357d13.htm
EX-4.2 - EX-4.2 - Amphastar Pharmaceuticals, Inc.amph-20201231ex429405cd2.htm
10-K - 10-K - Amphastar Pharmaceuticals, Inc.amph-20201231x10k.htm

Exhibit 21.1

SUBSIDIARIES OF THE COMPANY

State of

Country of

Incorporation/

Incorporation/

Company Name

    

Organization

    

Organization

International Medication Systems, Limited

California

United States of America

Armstrong Pharmaceuticals, Inc.

Massachusetts

United States of America

Amphastar Nanjing Pharmaceuticals, Inc.

China

Nanjing Letop Biological Technology Co., Ltd.

China

Nanjing Hanxin Medical Technology Co., Ltd.

China

Hanxin Biomedical Testing Service Co., Ltd.

China

Nanjing Baixin Trading Co., Ltd.

China

Amphastar France Pharmaceuticals, S.A.S.

France

Amphastar UK Limited

United Kingdom

International Medication Systems (UK) Limited

United Kingdom